September 13, 2019

TGaS Industry-Leading Platform, Vendor Insights, Surpasses 10K Recommendations, Shares Key Findings

Philadelphia, PA, Sept. 13, 2019. TGaS® Advisors, a subsidiary of TRINITY, recently announced that Vendor InsightsTM, its proprietary vendor evaluation platform, just exceeded 10,000 recommendations from over 189 companies for a range of life sciences service providers. Launched in 2016, Vendor Insights (VI) has grown into a highly sought after, credible industry source for expert insights from customers. Surpassing this data point marks a major milestone for the peer-reviewed vendor assessment solution.

TGaS Advisors is the premier provider of fact-based, peer-to-peer benchmarking and intelligence, helping biotech and pharmaceutical operations leaders to drive commercial excellence. TGaS President Gary McWalters congratulated the Vendor Insights (VI) team on their achievement. "VI's success demonstrates the value innovative vendors bring to biopharma, even in today's competitive environment," he said. "TGaS data provides an unbiased view into how vendors are utilized and where biotech and pharma companies see the most value across a variety of ratings. The VI portal has revealed that 80% of pharma spending goes to support commercialization efforts through partnerships with trusted, external vendors, an increase of 14% over the past 10 years.

About Vendor Insights

Vendor Insights (VI) was created by TGaS Advisors as a subscription service for pharmaceutical company executives to review service providers, rate products and services, and see how their ratings compare within their organization, as well as by peers throughout the industry. Vendors are able to create and manage a custom profile for their company, as well as their key products and services.

VI provides life sciences companies with a comprehensive set of peer ratings across virtually all business functions. The VI technology platform enables access to a deep repository of searchable vendor profiles, including product offerings by functional area, as well as reach, areas of specialization and utilization data. Users also have access to peer reviews, to see how others have used and reviewed vendors under consideration. Vendor Insights provides the biopharma industry with a comprehensive set of peer ratings for a range of vendors (including agencies, consultants, data, and software providers) across business functions.

VI recently asked participating companies to rate their vendors on two key attributes: impact and innovation. Over 80 respondents from a range of large, mid-tier, and emerging life sciences companies, nominated their top vendors and provided over 540 functional ratings for the study.

The study revealed two primary insights from the ratings, according to Tim Wohlgemut, SVP of New Products & Strategies for TRINITY. First, a shared set of core skills drives the most innovative, effective vendors to deliver meaningful results for their clients. In addition, achieving impact requires a commitment to partnership on both sides.

Overall, the study results indicated that a collaborative, engaged process is key to innovation. While novelty is important, a strategic approach and strong partnering behaviors were most critical. Vendors with the greatest impact were seen to be those that invest in their clients' vision, facilitate lasting change, and think both strategically and creatively. In terms of core skills, being strategic, customer-focused and having strong partnering behaviors were the most frequently mentioned attributes for those vendors identified in the survey. For more information go to http://www.tgas.com/solutions/tgas-vendor-insights/.

About TGaS Advisors

TGaS Advisors, a division of TRINITY, is the leading benchmarking and advisory services firm for commercial organizations in the life sciences industry. With a roster of large, emerging and precommercial life sciences companies, TGaS provides robust comparative intelligence and collaborative network membership services.

About TRINITY

TRINITY is a trusted strategic partner, providing evidence-based solutions for the life sciences. With over 20 years of experience, we are committed to solving our clients' most challenging problems through exceptional levels of service, powerful tools, and data-driven insights. TRINITY's range of products and services includes industry-leading benchmarking solutions, powered by TGaS® Advisors. To learn more about how we are elevating life sciences and driving from evidence to action, visit trinitylifesciences.com.